Skip to content
Revlimid-lenalid

CELGENE

Revlimid-lenalid


“Revlimid” contains Drug / Molecule called “Lenalidomide”.

Lenalidomide is an immunomodulatory agent, with antiinflammatory activity and anti-angiogenic effects. It acts by inhibiting cell proliferation and induction of apoptosis in Multiple Myeloma cells. Revlimid helps to promote immune responses to prevent inflammation in the body.  

“Lenalid” is the generic version of "Revlimid" and both contains same drug “Lenalidomide”.


Indication

Revlimid is used to treat a certain type of Myelodysplastic Syndrome and Multiple Myloma (a group of conditions in which the bone marrow produces blood cells that are mishappen and does not produce enough healthy blood cells) caused by an abnormal chromosome.

Note

SCHEDULE H PRESCRIPTION DRUG – CAUTION

SIDE EFFECTS :

  • Serious potential side effects are thrombosis, pulmonary embolus and hepatotoxicity, as well as bone marrow toxicity resulting in neutropenia and thrombocytopenia.
  • Common side effects include: diarrhea, itching, rashes, tiredness
  • These are all the possible side effects of Revlimid. Tell your healthcare provider about any side effect that bothers you or that does not go away.

 

INTERACTIONS :

  • Periodic monitoring of digoxin plasma levels is recommended during administration of Lenalidomide.
  • Acetyl digitoxin may decrease the Cardiotoxic activities of Lenalidomide.
  • Tacrolimus may increase the immunosuppressive activities of Lenalidomide.
  • The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Lenalidomide.
  • Bevacizumab may increase the Cardiotoxic activities of Lenalidomide.
  • Do not start, stop, or change the dosage of any medicines without your doctor's approval.

 

OVERDOSE :

  • Do not use more than prescribed dose.
  • If you suspect you may have overdosed, call your healthcare provider.
  • Do not take extra dose to make up for the missed dose.

Precaution

  • Revlimid is a prescription drug and should be used under proper medical guidance and advice.
  • Revlimid should never be taken by pregnant women or women capable of becoming pregnant as even a single dose cane cause severe birth defects or death to an unborn baby.

 

 

 

Updated On Oct 15, 2019 by Admin

Strength

5 mg, 10 mg, 15 mg & 25 mg

Packing

1 X 21 Capsules (Strip)

Storage

Store in a cool place, protect from light.

Revlimid-lenalid also available as


Fast moving

NATCO PHARMA LIMITED (INDIA)

Lenalid


“Lenalid” contains the drug / molecule called “Lenalidomide”. Lenalidomide is an immunomodulatory agent, with antiinflammatory activity and anti-angiogenic effects. It acts by inhibiting cell proliferation and induction of apoptosis in Multiple Myeloma cells. Lenalid helps to promote immune responses to prevent inflammation in the body.  





Related Products


NATCO PHARMA LIMITED (INDIA)

Lenalidomide-lenalid

NATCO PHARMA LIMITED. (INDIA)

Bortenat

NATCO PHARMA LIMITED (INDIA)

Bortezomib-bortenat


Most Viewed Products


CIPLA LTD. (INDIA)

Abiraterone acetate-xbira

NATCO PHARMA LIMITED (INDIA)

Bendamustine-bendit

CIPLA LTD. (INDIA)

Bicalutamide-cassotide

NATCO PHARMA LIMITED (INDIA)

Bortezomib-bortenat

NATCO PHARMA LIMITED (INDIA)

Erlonat

Biocon Limited

Everolimus-evertor

NATCO PHARMA LIMITED (INDIA)

Exemestane-xtane

NATCO PHARMA LIMITED (INDIA)

Geftinat

NATCO PHARMA LIMITED (INDIA)

Glatiramer acetate-glatimer

NATCO PHARMA LIMITED (INDIA)

Ledipasvir & sofosbuvir-hepcinat lp

NATCO PHARMA LIMITED (INDIA)

Lenalidomide-lenalid

NATCO PHARMA LIMITED (INDIA)

Pomalidomide-pomalid

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat

CIPLA LTD. (INDIA)

Tenofovir-tenvir

Top Products

Lenvatinib  | Sunishil

Sunitinib-Sutinat

Sunitinib-Sutinat

Quick Query

Direct to your Phone